Thomson Medical Group has narrowed its losses for the 1HFY2026 period ended Dec 31, 2025, by 20.6% to $10.2 million from a loss of $12.9 million a year ago.
While the group remained in a net loss position, the narrower loss reflected lower net finance costs and steady operating performance, even as Thomson Medical sustained investments in specialist services, clinical talent and digital initiatives across its markets.
This comes on the back of a 7.0% increase in revenue to $213.1 million from $199.1 million last year. The group attribute its revenue improvement to its core businesses as it advances its long-term transformation.
